Related Experiment Video
Updated: Mar 12, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.8K
Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis
D M Gujral1, M Long2, J W G Roe3
1Head and Neck Unit, The Royal Marsden Hospital, London, UK.
Summary
Carotid-sparing intensity-modulated radiotherapy (IMRT) for early glottis cancer shows promise but lacks consensus on target volumes and dose constraints. Further research is needed to establish its long-term benefits and standardize protocols.
Area of Science:
- Radiation Oncology
- Head and Neck Cancer Research
Background:
- Carotid-sparing intensity-modulated radiotherapy (IMRT) is being explored for early laryngeal glottis cancer to mitigate long-term carotid toxicity.
- Concerns exist regarding potential geographical misses and other normal tissue toxicities associated with this technique.
Purpose of the Study:
- To systematically review the current literature on carotid-sparing IMRT for early glottis cancer.
- To focus on the definitions of target volumes and carotid arteries as organs at risk.
- To propose recommendations for standardizing structures, dose constraints, and dose reporting.
Main Methods:
- A systematic review of 16 articles, selected from 73 references.
- Included studies comprised two case reports, 11 planning studies, and three prospective studies.
Main Results:
- Significant variation and lack of consensus were found in target volume definitions, particularly for the clinical target volume.
- Carotid artery and spinal cord delineation were inconsistently defined, and most studies lacked specific carotid artery dose constraints.
- Delineation of carotid artery length varied across studies, despite most reporting mean doses.
Conclusions:
- A lack of consensus in target volume definitions for carotid-sparing IMRT is evident.
- Long-term prospective data are essential to confirm the benefits of carotid-sparing IMRT.
- Establishing consensus on target volume definition, dose constraints, and reporting is crucial for future standardization.

